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Abstract
Introduction
Non-medical prescribing has the potential to deliver innovative healthcare within limited
finances. However, uptake has been slow, and a proportion of non-medical prescribers do
not use the qualification. This systematic review aimed to describe the facilitators and barri-
ers to non-medical prescribing in the United Kingdom.
Methods
The systematic review and thematic analysis included qualitative and mixed methods
papers reporting facilitators and barriers to independent non-medical prescribing in the
United Kingdom. The following databases were searched to identify relevant papers:
AMED, ASSIA, BNI, CINAHL, EMBASE, ERIC, MEDLINE, Open Grey, Open access theses
and dissertations, and Web of Science. Papers published between 2006 and March 2017
were included. Studies were quality assessed using a validated tool (QATSDD), then under-
went thematic analysis. The protocol was registered with PROSPERO (CRD42015019786).
Results
Of 3991 potentially relevant identified studies, 42 were eligible for inclusion. The studies were
generally of moderate quality (83%), and most (71%) were published 2007–2012. The nursing
profession dominated the studies (30/42). Thematic analysis identified three overarching
themes: non-medical prescriber, human factors, and organisational aspects. Each theme con-
sisted of several sub-themes; the four most highly mentioned were ‘medical professionals’, ‘area
of competence’, ‘impact on time’ and ‘service’. Sub-themes were frequently interdependent on
each other, having the potential to act as a barrier or facilitator depending on circumstances.
Discussion
Addressing the identified themes and subthemes enables strategies to be developed to sup-
port and optimise non-medical prescribing. Further research is required to identify if similar
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themes are encountered by other non-medical prescribing groups than nurses and
pharmacists.
Introduction
The drive behind non-medical prescribing in the United Kingdom (UK) is the need to deliver
high-quality healthcare to patients where and when they require it, within a limited financial
resource [1–3]. Innovative patient centred care pathways are being developed, using the most
appropriate healthcare professionals, such as clinical pharmacists in general practice [4], or
prescribing physiotherapists streamlining musculoskeletal pathways [5]. The extension of
non-medical prescribing to other professional groups continues; with pressure for physician
associates to become prescribers [6] and paramedics; who were unsuccessful at the last consul-
tation [7].
Non-medical prescribing evolved from limited list prescribing for a few nurses in the early
1990s to the current range of eligible healthcare professionals (Table 1). Each healthcare pro-
fessional must successfully complete an appropriate and approved prescribing course, and be
registered as a prescriber with their relevant regulatory body. Professionally, they are expected
to prescribe within their competency area [8, 9].
The initial uptake of non-medical prescribing was slow, with approximately 240 pharma-
cists and 4000 nurses having qualified by 2005 [10], the later contrasting with the government’s
anticipated 10000 nurses [11]. A recent report identified that approximately 53000 nurses and
over 3800 pharmacists were registered as prescribers in 2015 [12], but was unable to identify
how many were active. Previous survey evidence indicated 14% of nurse independent prescrib-
ers and 29% of pharmacist independent prescribers were not using their prescribing qualifica-
tion [10], and other estimates [13] indicate under 10% of nurse independent prescribers and
nearly 40% of pharmacist and allied health professional prescribers are not using their pre-
scribing qualification. Similarly, surveys conducted by the General Pharmaceutical Council
indicate varying uptake of prescribing activity. In a 2016 survey of prescribing pharmacists
nearly 90% of pharmacist prescribers were reported as active [14], whereas the previous 2014
report had found that only 61% had prescribed in the previous year [15]. The 2016 survey had
a poor response rate (<18%) possibly overestimating activity through responder bias.
The full cost of training a non-medical prescriber (NMP) has been calculated as approxi-
mately £10000 [10] and, with increasing demand on the NHS and limited funding, there is a
Table 1. Evolution of non-medical prescribing in the UK.
2002 Extended formulary prescribing for nurses
2003 Supplementary prescribing for nurses and pharmacists
2005 Independent prescribing for nurses and pharmacists
Supplementary prescribing for physiotherapists, podiatrists, and therapeutic and diagnostic radiographers
2008 Independent prescribing for optometrists
2012 Independent prescribing for physiotherapists and podiatrists
2016 Independent prescribing for therapeutic radiographers
Supplementary prescribing for dieticians
An independent prescriber is responsible for the care of the patient, including prescribing.
A supplementary prescriber works in collaboration with an independent prescriber and the patient to prescribe
according to a pre-determined treatment scheme.
https://doi.org/10.1371/journal.pone.0196471.t001
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need to realise the full benefit of training investment. Previous studies have identified reasons
for not prescribing including lack of support from colleagues or within their work environ-
ment [13, 14], or a role change [10]; but did not explore these issues in depth. A previous the-
matic literature review of supplementary prescribing did not address the issue of barriers and
facilitators specifically, but identified a limited number including: medical practitioner sup-
port, communication, resource limitations and specific supplementary prescribing aspects
[16]. It also did not address independent prescribing. There has been no robust review of the
qualitative literature relating to barriers or facilitators of independent non-medical prescrib-
ing. Identifying facilitators and barriers to independent non-medical prescribing has the
potential for strategy development to optimise its implementation.
The aim of this review was to evaluate the use, facilitators, and barriers of independent
non-medical prescribing in primary and secondary care in the UK.
Methods
Search strategy and selection criteria
A systematic review and thematic synthesis was conducted to explore the barriers and facilita-
tors to non-medical independent prescribing in the UK. A protocol for the review was devel-
oped in advance, following the PRISMA-P statement [17], and registered with PROSPERO
(CRD42015019786). The results are reported in accordance with the PRISMA and ENTREQ
statements (S1 and S2 Appendices) [18, 19].
Qualitative and mixed methods research studies investigating independent non-medical
prescribing in the UK were included. Narrative reports describing a service, opinion papers
and abstracts were excluded [20]. The legislation permitting independent prescribing by
nurses and pharmacists was enacted in 2006 and therefore only studies published since 2006
were included [21]. There was no language restriction.
Specific search strategies were developed with expert librarian support, for each electronic
database, and included broad and narrow, free text, and thesaurus based terms [22]. Boolean
operators and truncation were used. The selected keywords were: nurse, pharmacist, physio-
therapist, podiatrist, non-medical, therapist, allied health professional, chiropodist, indepen-
dent prescribing, utilisation, barriers, facilitators, role, education, support, guidelines, policy,
procedures, attitudes and clinic. The following databases were searched: AMED, ASSIA, BNI,
CINAHL, EMBASE, ERIC, MEDLINE, Open Grey, Open access theses and dissertations, and
Web of science. Papers that cite, or were cited by, the included papers were screened to identify
any further relevant papers. Searches were completed to 26 March 2017 (S3 Appendix. Med-
line (Ovid) search strategy).
Titles/abstracts obtained from all searches were screened to remove duplicates and papers
that did not meet the eligibility criteria. Full text copies of the papers remaining were obtained
and reviewed. Two independent reviewers (EGC and TN) conducted each stage and resolved
differences by discussion, with a third reviewer (AR) available for mediation if required [23].
Numbers excluded at each stage were recorded [18, 23].
Quality assessment
A validated quality assessment tool, (Quality Assessment Tool for Studies of Diverse Designs,
QATSDD), was used to assess the studies [24]. The tool was developed to support quality anal-
ysis where studies use different designs, including qualitative, quantitative, and mixed meth-
ods. The tool comprises 16 elements (listed in S1 Table. QATSDD scores for each paper)
covering aspects such as theoretical approach, research setting, data collection, and method of
analysis. Each element is rated on a scale of 0 –no evidence, to 3 –full details, with clear reasons
Facilitators and barriers to non-medical prescribing
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defined for each score. Twelve elements are common to all studies, with two specific elements
each for qualitative and quantitative studies. The studies included in this review used a variety
of research methods, primarily interviews, questionnaires and focus groups, making this tool
suitable. Two reviewers (EGC and TN) independently assessed the studies using the tool;
resolving any disagreement in the scores through discussion. Including low quality studies in a
qualitative systematic review is debated, with some researchers arguing for their inclusion as
they may provide valuable insights, whereas others argue they should be excluded [20, 25, 26].
The decision was taken to include all studies to inform synthesis and conclusions regardless of
quality assessment, but to report on the quality assessment results (see Table 2), particularly as
from an initial scoping search, limited studies were identified.
Analysis
Thematic analysis, to identify recurrent barriers and facilitators to non-medical prescribing and
themes relating to use, was conducted on text from the results and findings sections of the
papers together with any included participant quotations [69, 70]. The studies were read to
identify initial emerging themes, and then underwent line by line thematic coding utilising
NVivo111 (QSR International). As further themes emerged, new codes were created. All codes
and themes were reviewed iteratively for consistency and appropriateness and amended if nec-
essary. The findings were summarised under descriptive theme headings, permitting develop-
ment of a hierarchy. The analysis was conducted by one researcher (EGC) and the initial
themes and coding discussed and critically debated by all authors. The final version was agreed
by all authors following further refinement of the theme headings and hierarchy. At the end of
data analysis no further themes were identified, indicating that data saturation had been reached
[70]. EGC is a practising NMP, and an NMP lead with a role in supporting other NMPs. This
researcher standpoint was balanced by the other three authors, none of whom are prescribers.
Results
The search strategy identified 3991 potentially relevant studies. Following exclusion of 459
duplicates and 3436 from title and abstract review, 96 studies were reviewed at the full text
stage. Following exclusions, 42 papers were included (Fig 1. PRISMA flow diagram).
Overall, the studies were assessed as moderate quality. There were three low scoring papers
[30, 57, 58] (score<25%), and four high scoring papers [27, 31, 43, 52] (score>75%); the latter
being doctoral theses (S1 Table. QATSDD scores for each paper). Key issues highlighted by the
scores were poor reporting of theoretical framework, data collection tool choice, analytical
method justification, research question and analytical method fit, and user involvement.
Of the 42 papers, 30 (71%) were published between 2007 and 2012, with the remainder pub-
lished subsequently. Nurse independent prescribers were studied in 24 papers [28–32, 34–38,
40, 42, 44, 46, 48, 50, 58–60, 62, 64–67], pharmacist prescribers in five papers [43, 49, 54, 55,
57], and a mixture of nurse and pharmacist prescribers in a further six papers [27, 33, 47, 52,
53, 61]. The remaining papers investigated the views of patients and staff associated with
NMPs [39, 41, 45, 51, 56, 63, 68].
Thematic analysis identified 17 subthemes of which 15 described the factors that may
impact on NMPs and two described the range of activity. These were grouped into three over-
arching themes, which were 1) factors relating to the NMP themselves, 2) human factors and
3) organisational aspects. The themes and subthemes are presented in Table 3, together with
example factors, and S2 Table lists the papers that the themes were identified in. The 15 sub-
themes impacting on non-medical prescribing contained factors which could be barriers or
facilitators; in many instances, this was dictated by circumstances.
Facilitators and barriers to non-medical prescribing
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Non-medical prescriber themes
Factors affecting the NMP were subdivided into those arising from the attitude of the NMP
and those derived from their practice (See Table 3). Prescribing enabled the professional to
practice autonomously [21, 28, 31, 37, 42, 46, 65], enhancing job satisfaction [31, 37, 42, 46, 47,
49, 65], and supporting professional development [27, 33, 47, 50]. Some practitioners, how-
ever, expressed anxiety [29, 37] and cautiousness [27, 48, 52, 65]. Practitioners indicated that
their area of competency enabled them to prescribe confidently [44, 48, 52, 65–67], and to
resist pressure to prescribe outside this area [34, 44, 52, 65–67]. Roles were enhanced through
including prescribing [27, 33, 35, 37, 42, 44, 58, 63, 67].
Fig 1. PRISMA flow diagram.
https://doi.org/10.1371/journal.pone.0196471.g001
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Table 2. Characteristics and details of selected papers.
Author Population Setting and/or speciality Study type Participant
numbers
Results/Findings QATSDD
Adigwe (2012)
[27]
NMPs
Patients
Primary & secondary
care
1) SSI-F2F
2) Online survey
3) SSI-F2F
1) NP (n = 9)
PP (n = 13)
2) NP (n = 141)
PP (n = 27)
Other NMP
(n = 11)
3) Patients (n = 12)
Supportive mechanisms & safe
prescribing environment required to
support prescribers
90%
Armstrong
(2015) [28]
Senior nurse
Medical consultant
NP
Nurse
Pharmacist
Patients
Urgent care setting—one
hospital
1) SSI
2) Questionnaire
1) Senior nurse
(n = 1)
Doctor (n = 1)
NP (n = 2)
Nurse (n = 1)
Pharmacist (n = 1)
2) Patients (n = 20)
Benefits of autonomous working
identified by staff & patients.
45%
Bennett et al
(2008) [29]
Practising NP HIV clinics—community
& secondary care
1) postal
questionnaire
2) Focus group
1) NP (n = 8)
2) NP (n = 7)
Impact of prescribing on NP/doctor
and patient relationships discussed.
Overall perceived to be beneficial.
45%
Bewley (2007)
[30]
Recently qualified
nurses
Senior paediatric
nurses
NP
HEI
Paediatrics 1) Facilitated
workshop
2) Facilitated
workshop
3) Narrative
4) Semi-structured
questionnaire
5) Scoping exercise
1) Recently
qualified nurses
(n = 35)
2) Senior paediatric
nurses (n = ?)
3) NP (n = 1)
5) NP (n = 19)
5) HEI (n = 4)
Pharmacology knowledge poor during
nurse training. Identified as challenging
in NMP course.
14%
Bowskill
(2009) [31]
NP Primary & secondary
care
SSI NP (n = 26) Trust between nurse and doctor
identified as necessary for a successful
prescribing partnership.
90%
Bowskill et al
(2013) [32]
NP Primary & secondary
care
SSI NP (n = 26) Trust between nurse and doctor
identified as necessary for a successful
prescribing partnership.
Secondary care practitioners had more
restrictions.
60%
Brodie et al
(2014) [33]
PP
NP
Primary care SSI-F2F PP (n = 4)
NP (n = 4)
PP/NP have holistic approach to
treatment. Concerns they were
underutilised.
38%
Carey et al
(2009) [34]†
NP Specialist children’s
hospital—Intrinsic case
study
Interviews NP (n = 7
participants, 18
interviews)
NMP believed to improve care
provided to patients.
55%
Carey et al
(2009) [35]†
NP
Doctors
DMPs
Clinical Leads
Specialist children’s
hospital—Intrinsic case
study
SSI-F2F NP (n = 7
participants, 18
interviews)
Doctors (n = 4)
DMPs (n = 7)
Clinical Leads
(n = 3)
Successful NMP implementation but
variations in approach and
expectations.
48%
Carey et al
(2010) [36]‡
NP
Doctors
Administration staff
Non-nurse prescribers
Dermatology services—
primary & secondary
care– 10 site collective
case study
SSI-F2F NP(n = 11)
Doctors (n = 12)
Administration
staff (n = 11)
Non-nurse
prescribers (n = 6)
NMP improved access to treatment,
with ability for service reconfiguration.
Inconsistent support post-training.
45%
Carey et al
(2014) [37]
NP Respiratory conditions -
Primary & secondary
care, East of England
SHA
SSI—telephone NP (n = 39
Non-prescribing
NP (n = 1)
Wide variations in practice, but overall
improved service to patients. Several
challenges to NMP identified.
62%
(Continued)
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Table 2. (Continued)
Author Population Setting and/or speciality Study type Participant
numbers
Results/Findings QATSDD
Courtenay
et al (2008)
[38]
NP Primary & secondary
care
Questionnaire NP (n = 1377) Nearly 70% of NP reported problems
with implementing NMP.
56%
Courtenay
et al (2009)
[39]†
Doctors
DMPs
Clinical leads
Specialist children’s
hospital—Intrinsic case
study
F2F interviews Doctors (n = 7)
DMPs (n = 4)
Clinical leads
(n = 3)
Benefits in improving services to
patients identified, but concerns raised
regarding roles and NMP selection.
71%
Courtenay
et al (2009)
[40]‡
NP
Doctors
Administration staff
Non-nurse prescribers
Patients
Dermatology services—
primary & secondary
care– 10 site collective
case study
1) SSI-F2F
2) Videotaped
observations
3) Questionnaire
1) NP (n = 10)
Doctors (n = 12)
Administration
staff (n = 11)
Non-nurse
prescribers (n = 6)
2) NP (n = 37)
3) Patients
(n = 165)
Benefit to care reported by patients. 56%
Courtenay
et al (2011)
[41]
NMP leads, of whom
half had a prescribing
qualification
Primary & secondary
care—one SHA
SSI NMP leads (n = 28) Four key aspects of role identified:
information, promotion, clinical
governance, and training
52%
Cousins et al
(2012) [42]
NP General practice SSI-F2F NP (n = 6) NMP enhanced job satisfaction, but
increased work-related stress.
57%
Dapar (2012)
[43]
PP Community, primary &
secondary care
1) Questionnaire
2) Telephone
interview
1) PP (n = 695/
1643)
2) PP (n = 34)
Implementation of NMP requires
support, and ability to overcome
challenges. NMP role clarification
required.
98%
Daughtry et al
(2010) [44]
NP One PCT, north England SSI NP (n = 8) NMP expands role, but
misunderstandings exist with other
work colleagues.
38%
Dobel-Ober
et al (2010)
[45]
Nursing directors Mental health trusts—
England
Postal questionnaire Directors of
nursing (n = 39/66)
Majority of trusts had policies and
strategies supporting NMP. Only 1
Trust had no NMPs.
46%
Downer et al
(2010) [46]
NP Community—two health
boards, Scotland
Conversational F2F
interviews
NP (n = 8) Benefits to self and patients identified,
but also challenges, including lack of
support.
48%
Green et al
(2008) [47]
NP (n = 12)
PP (n = 1)
Mental health trust—
Humber
Email qualitative
survey
NMP (n = 10)
(profession not
indicated)
50% prescribing, others providing
advice. NMP qualification of positive
benefit.
48%
Herklots et al
(2015) [48]
NP Community—two PCTs SSI NP (n = 7) NMP enhanced role, and knowledge
from course beneficial to wider
practice. Support, inc. CPD, variable.
50%
Hill et al
(2014) [49]
Patients
PP
GPwSI
Addiction services—
Lanarkshire
1) SSI based on
questionnaire
2) Questionnaire
alone
1) Patients (n = 86)
PP (n = 5)
2) GPwSI (n = 6)
Overall satisfaction with PP led clinic,
with enhanced job satisfaction.
33%
Kelly et al
(2010) [50]
Practice nurses, +/-
prescribing
qualification
Primary care—one
southern English county
Postal questionnaire No prescribing
qualification
(n = 120)
NP (n = 31)
46% respondents not intending to train
as NMP, citing various issues relating to
the course and age as reasons
35%
Maclure et al
(2013) [51]
General public Scotland Postal questionnaire General public
(n = 1855/5000)
General support for NMP, but several
concerns raised.
43%
(Continued)
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Table 2. (Continued)
Author Population Setting and/or speciality Study type Participant
numbers
Results/Findings QATSDD
Maddox
(2011) [52]§
PP
NP
Primary & community—
predominantly NW
England
1) Unstructured
interviews
2) Focus group x 3
3) SSI (F2F or
telephone)
4) Q-method
1) PP (n = 4)
NP (n = 14)
2) NP (n = 10)
3) PP (n = 5)
NP (n = 15)
4) PP (n = 22)
NP (n = 34)
NMPs most confident when
prescribing within guidelines. ‘Time
burden’ for DMPs acknowledged as
significant.
95%
Maddox et al
(2016) [53]§
PP
NP
Primary & community—
predominantly NW
England
1) SSI (F2F or
telephone)
2) Focus group x 3
1) PP (n = 5)
NP (n = 15)
2) NP (n = 10)
NMPs cautious when prescribing,
confidence improved with good
support.
69%
McCann et al
(2011) [54]¶
PP Primary & secondary
care—Northern Ireland
Postal structured
self-administered
questionnaire
PP (n = 76/100) Over 50% had or were not prescribing.
Issues included lack of funding and lack
of GP awareness.
42%
McCann et al
(2012) [55]¶
PP
DMP
Key stakeholders
Primary & secondary
care—Northern Ireland
SSI-F2F PP (n = 11)
DMP (n = 8)
Stakeholders
(n = 13)
Benefits of holistic care for patient and
team working identified, together with
several challenges.
60%
McCann et al
(2015) [56]¶
PP Patients 3 case studies,
primary & secondary care
—Northern Ireland
Focus Groups x 7 Patients (n = 34) Lack of prior awareness of PP. Patients
identified benefits of team approach,
but expressed some reservations.
62%
Mulholland
(2014) [57]
PP
Non-prescribing
pharmacists
Neonatal units, United
Kingdom
Electronic survey PP (n = 22)
Non-prescribing
pharmacists
(n = 23)
NMP identified as a team benefit, with
utilisation of pharmacist knowledge.
23%
Mundt-Leach
(2012) [58]
NP NHS addiction services Telephone survey NP (n = 20) Benefits of NMP for patients felt to
outweigh challenges.
21%
Oldknow et al
(2010) [59]
NP
Consultant
psychiatrists
Patients
Older peoples’ mental
health services—one
mental health trust
1) F2F interviews
2) Postal survey
3) Document review
1) Participants
unknown (n = ?)
2) Patients (n = 16/
58)
3) Unknown
Report of a pilot implementation of
NMP, which indicated service benefits.
35%
Oldknow et al
(2013) [60]
Non-prescribing NP One mental health trust Interviews Non-prescribing
NP (n = 6)
Several barriers identified, including
lack of remuneration.
71%
Ross (2015)
[61]
NP
PP
Nurse manager
Consultant
psychiatrists
GP
Patients
Mental health—Tees, Esk
& Wear Valleys NHSFT
1) Focus groups x 9
2) Interviews—F2F
& telephone (n = 13)
1) & 2)
Distribution
unknown.
NP (n = 35)
PP (n = 3)
Nurse manager
(n = 2)
Consultant
psychiatrists
(n = 7)
GP (n = 1)
Patients (n = 9)
Patient/NP relationship positive with
benefit seen by all participants. De-
prescribing highlighted as an important
role.
60%
Ross et al
(2012) [62]
NP Mental health—Scotland 3) Email/postal
Questionnaire
4) Focus group
1) NP (n = 33/60)
2) NP (n = 12)
Majority of NMPs yet to prescribe.
Numerous barriers identified including
lack of support from employer and lack
of adequate remuneration.
71%
Shannon et al
(2011) [63]
GP
Cardiac physician
Heart Failure—one
primary care centre &
one hospital, West
Scotland
1) Focus groups x 4
2) 1-2-1 interviews
1) GP (n = 9)
Cardiac physician
(n = 8)
2) GP (n = 1)
Cardiac physician
(n = 3)
Participants generally supportive of
NMP, but identified communication as
a key challenge.
57%
(Continued)
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Human factor themes
Human factors described the impact that NMPs had on their patients, colleagues, and manag-
ers, and the impact that these people had on the NMP themselves. Medical staff that had been
involved in the training of NMPs [39, 54, 63] were more supportive than those who were
unaware of the training involved [39, 43]. This was regardless of seniority [55, 66]; junior med-
ical staff were less likely to be supportive [39]. Managers were instrumental in developing and
supporting the NMP role [27, 36, 41, 43]. Lack of support, flexibility or understanding by man-
agers hindered the implementation and development of non-medical prescribing [27, 29, 31,
32, 37, 46, 52, 54, 61, 66, 67]. NMPs gained support from colleagues, describing enhanced
team working [27, 32, 34, 35, 41, 43, 47–49, 55, 57, 65–67], and were perceived as supportive
experts and leaders [27, 32, 43, 47, 67]. However, NMPs encountered opposition from some
colleagues [21, 27, 31, 32, 38, 43, 44, 47, 52, 62, 66].
Organisational aspect themes
Organisational aspects encompassed a range of themes covering administration, development
and service delivery. Administration comprised three subthemes: formulary, policy, and
Table 2. (Continued)
Author Population Setting and/or speciality Study type Participant
numbers
Results/Findings QATSDD
Stenner et al
(2007) [64]k
NP Acute, chronic &
palliative pain—
community, primary &
secondary care
SSI-F2F NP (n = 26) NMPs more likely to provide advice on
treating
chronic pain patients than prescribe.
Reasons for this include budgetary
restrictions.
57%
Stenner et al
(2008) [65]k
NP Acute, chronic &
palliative pain—
community, primary &
secondary care
SSI-F2F NP (n = 26) Many benefits to NMP identified,
resulting from autonomous practice.
52%
Stenner et al
(2008) [66]k
NP Acute, chronic &
palliative pain—
community, primary &
secondary care
SSI-F2F NP (n = 26) Multi-disciplinary team working
benefits both NMPs and other team
members. Support from policies and
CPD identified as important.
67%
Stenner et al
(2010) [67]
NP
Doctors
Administration staff
Non-prescribing
nurse
Diabetes—community,
primary & secondary care
—9 site collective case
study
SSI NP (n = 10)
Doctors (n = 9)
Administration
staff (n = 9)
Non-prescribing
nurse (n = 3)
Prescribing incorporated into existing
role, with support from other staffs.
Some issues initially, but now mainly
resolved.
50%
Stenner et al
(2011)[68]
Patients Diabetes—6 sites,
Primary care
SSI Patients (n = 41) Patients identified a range of benefits
from NMP, including improved disease
management.
57%
 paper derived from linked theses.
§ paper derived from linked theses.
† linked reports of data from one study.
‡ linked reports of data from one study.
¶ linked reports of data from one study.
k linked reports of data from one study.
DMP, designated medical practitioner; F2F, Face-to-Face; GP, general practitioner; GPwSI, GP with a special interest; HEI, Higher education institute; NHSFT,
National Health Service Foundation Trust; NP, nurse prescriber; NMP, non-medical prescriber; PP, pharmacist prescriber; PCT, primary care trust; QATSDD, Quality
Assessment of Studies of Diverse Designs; SHA, strategic health authority; SSI, Semi-Structured interviews
https://doi.org/10.1371/journal.pone.0196471.t002
Facilitators and barriers to non-medical prescribing
PLOS ONE | https://doi.org/10.1371/journal.pone.0196471 April 30, 2018 9 / 18
T
a
b
le
3
.
T
h
e
th
em
es
a
n
d
su
b
th
em
es
th
a
t
in
fl
u
en
ce
n
o
n
-m
ed
ic
a
l
p
re
sc
ri
b
in
g
.
T
h
em
e
S
u
b
,
a
n
d
su
b
su
b
,
th
em
es
Q
u
o
ta
ti
o
n
s
In
te
rp
re
ta
ti
o
n
/e
x
a
m
p
le
fa
ct
o
rs
1
.
N
o
n
-m
ed
ic
al
p
re
sc
ri
b
er
1
.1
.
A
tt
it
u
d
e
[2
7
–
2
9
,
3
1
–
3
5
,
3
7
,
4
0
,
4
2
,
4
4
,
4
6
–
5
0
,
5
2
,
5
3
,
6
1
,
6
5
–
6
7
]
“I
th
in
k
it
’s
b
ee
n
a
m
ar
v
el
o
u
s
(s
ic
)
th
in
g
re
al
ly
an
d
it
’s
b
ee
n
g
o
o
d
,
it
’s
g
o
o
d
fo
r
m
y
co
n
fi
d
en
ce
,
it
’s
g
iv
en
m
e
a
lo
t
to
th
in
k
ab
o
u
t.
It
’s
g
iv
en
m
e
a
n
ew
st
ri
n
g
to
a
b
o
w
,
it
,
k
ee
p
s
m
e
in
te
re
st
ed
.”
[3
7
]
“i
t
sc
ar
es
th
e
h
el
l
o
u
t
o
f
m
e
ev
en
th
o
u
g
h
I
am
au
to
n
o
m
o
u
s
in
m
y
cl
in
ic
s.
I
st
il
l
af
te
r
d
o
in
g
a
p
re
sc
ri
p
ti
o
n
h
av
e
to
g
et
a
G
P
to
si
g
n
to
ch
ec
k
”
[5
0
]
Jo
b
sa
ti
sf
ac
ti
o
n
an
d
co
n
fi
d
en
ce
o
f
th
e
p
ra
ct
it
io
n
er
s
en
h
an
ce
d
b
y
n
o
n
-
m
ed
ic
al
p
re
sc
ri
b
in
g
.
L
ac
k
o
f
co
n
fi
d
en
ce
an
d
an
x
ie
ty
ca
n
p
re
v
en
t
p
ra
ct
it
io
n
er
fr
o
m
u
si
n
g
p
re
sc
ri
b
in
g
sk
il
ls
.
A
tt
it
u
d
e
to
w
ar
d
s
N
M
P
an
d
ro
le
ca
n
b
e
af
fe
ct
ed
b
y
v
ie
w
s
o
f
o
th
er
s.
1
.2
.
P
ra
ct
ic
e
1
.2
.1
.
A
re
a
o
f
co
m
p
et
en
ce
[2
7
,
3
1
–
3
5
,
3
7
,
3
8
,
4
0
,
4
2
–
4
4
,
4
8
–
5
3
,
5
5
–
5
8
,
6
5
–
6
8
]
“.
..
w
it
h
co
n
tr
ac
ep
ti
o
n
I
th
o
u
g
h
t
b
ef
o
re
I
st
ar
t
in
it
ia
ti
n
g
n
ew
p
il
ls
I
re
al
ly
w
an
t
to
d
o
an
u
p
d
at
e
an
d
I
w
as
en
co
u
ra
g
ed
to
d
o
th
at
q
u
ic
k
ly
.
It
h
as
g
iv
en
m
e
a
lo
t
m
o
re
co
n
fi
d
en
ce
to
p
re
sc
ri
b
e
in
th
at
ar
ea
”
[2
7
]
“S
o
m
e
o
f
o
u
r
p
at
ie
n
ts
n
o
w
w
o
u
ld
b
e
m
o
re
d
if
fi
cu
lt
to
m
an
ag
e
y
o
u
k
n
o
w
p
at
ie
n
ts
w
it
h
o
th
er
co
n
d
it
io
n
s
li
k
e
so
m
e
o
f
o
u
r
an
ae
m
ia
p
at
ie
n
ts
as
w
el
l
as
b
ei
n
g
re
n
al
ar
e
al
so
o
n
co
lo
g
y
p
at
ie
n
ts
an
d
th
at
m
ak
es
th
em
a
b
it
m
o
re
aw
k
w
ar
d
an
d
th
o
se
p
at
ie
n
ts
I
w
o
u
ld
d
ef
in
it
el
y
re
fe
r
b
ef
o
re
u
p
p
in
g
o
r
d
ec
re
as
in
g
a
d
o
se
”
[5
5
]
C
o
n
fi
d
en
ce
g
ai
n
ed
b
y
d
ef
in
ed
ar
ea
o
f
co
m
p
et
en
ce
.
C
o
n
st
ra
in
ts
o
f
co
-m
o
rb
id
it
y
ac
k
n
o
w
le
d
g
ed
,
n
ee
d
to
re
fe
r
w
h
en
o
u
ts
id
e,
o
r
p
er
ce
iv
ed
to
b
e
o
u
ts
id
e,
co
m
p
et
en
ce
ar
ea
.
1
.2
.2
.
R
o
le
[2
7
,
2
8
,
3
1
–
3
7
,
4
2
–
4
4
,
4
6
,
4
7
,5
0
,
5
2
,
5
3
,
5
5
,
5
6
,5
8
,
6
2
,
6
3
,
6
5
–
6
7
]
“H
o
sp
it
al
tr
u
st
G
an
d
p
ri
m
ar
y
ca
re
tr
u
st
A
ag
re
ed
fo
r
th
e
n
u
rs
e
sp
ec
ia
li
st
to
ru
n
n
u
rs
e
le
d
cl
in
ic
s
in
p
ri
m
ar
y
ca
re
se
tt
in
g
s.
H
er
p
re
sc
ri
b
in
g
q
u
al
if
ic
at
io
n
h
as
en
ab
le
d
th
e
su
cc
es
sf
u
l
d
ev
el
o
p
m
en
t
o
f
th
is
n
ew
se
rv
ic
e
fo
r
p
at
ie
n
ts
.
W
it
h
o
u
t
a
n
u
rs
e
p
re
sc
ri
b
er
in
th
es
e
p
o
st
s
a
d
o
ct
o
r
is
re
q
u
ir
ed
to
b
e
p
re
se
n
t
in
th
e
co
m
m
u
n
it
y
to
p
re
sc
ri
b
e
fo
r
p
at
ie
n
ts
ac
ce
ss
in
g
h
ea
lt
h
ca
re
at
th
is
p
o
in
t.
“I
co
u
ld
n
’t
d
o
m
y
ro
le
w
it
h
o
u
t
n
u
rs
e
p
re
sc
ri
b
in
g
”“
[3
1
]
“I
h
av
e
to
d
ev
el
o
p
m
y
o
w
n
ro
le
;
fi
g
h
ti
n
g
to
fi
n
d
a
p
la
ce
in
b
et
w
ee
n
G
P
s
an
d
p
re
sc
ri
b
in
g
n
u
rs
es
”
[4
3
]
F
o
u
n
d
to
en
h
an
ce
ex
is
ti
n
g
ro
le
s.
S
u
cc
es
s
m
o
re
li
k
el
y
w
h
er
e
p
ra
ct
it
io
n
er
’s
ro
le
w
el
l-
d
ef
in
ed
o
r
w
h
en
ro
le
sp
ec
if
ic
al
ly
d
es
ig
n
ed
to
in
cl
u
d
e
p
re
sc
ri
b
in
g
.
S
u
cc
es
s
le
ss
li
k
el
y
w
h
en
la
ck
o
f
ro
le
cl
ar
it
y
,
w
h
er
e
ro
le
w
as
n
’t
v
al
u
ed
o
r
w
h
er
e
o
rg
an
is
at
io
n
al
is
su
es
co
n
st
ra
in
ed
ro
le
d
ev
el
o
p
m
en
t.
2
.
H
u
m
an
fa
ct
o
rs
2
.1
.
P
at
ie
n
ts
[2
7
–
2
9
,
4
3
,
4
7
,
4
9
,
5
1
,
5
6
,
5
9
,
6
1
,
6
3
,
6
7
,
6
8
]
“I
th
in
k
th
ey
(n
u
rs
e
p
re
sc
ri
b
er
s)
lo
o
k
at
al
l
th
e
ca
re
.
T
h
ey
w
il
l
ch
ec
k
th
at
th
e
d
ru
g
s
th
ey
h
av
e
p
re
sc
ri
b
ed
d
o
n
’t
cl
as
h
w
it
h
o
th
er
th
in
g
s.
T
h
ey
ar
e
in
te
re
st
ed
in
m
y
h
o
m
e
li
fe
.
T
h
ey
si
t
d
o
w
n
an
d
ta
k
e
an
in
te
re
st
so
y
o
u
d
o
n
’t
re
la
p
se
.”
[6
1
]
“M
y
o
n
e
(d
is
ad
v
an
ta
g
e)
w
o
u
ld
b
e
cr
o
ss
in
g
th
e
sp
ec
ia
li
sm
s–
cr
o
ss
in
g
th
e
il
ln
es
se
s.
M
y
ex
p
er
ie
n
ce
h
er
e
is
in
re
la
ti
o
n
to
d
ia
b
et
ic
m
an
ag
em
en
t,
b
u
t
I
w
o
u
ld
al
so
li
k
e
o
n
e
th
at
is
ap
p
re
ci
at
iv
e
o
f
m
y
o
v
er
al
l
(h
ea
lt
h
)”
[5
6
]
P
at
ie
n
ts
ap
p
re
ci
at
e
re
ce
iv
in
g
h
o
li
st
ic
ca
re
an
d
u
n
d
er
st
an
d
ab
le
in
fo
rm
at
io
n
fr
o
m
N
M
P
s.
C
o
n
ce
rn
s
ab
o
u
t
co
m
m
u
n
ic
at
io
n
w
it
h
G
P
,
an
d
th
at
N
M
P
m
ay
h
av
e
li
m
it
ed
k
n
o
w
le
d
g
e/
ab
il
it
y
to
d
ea
l
w
it
h
co
m
p
le
x
is
su
es
.
2
.2
.
S
ta
ff
2
.2
.1
.
M
an
ag
er
s
[2
7
,
2
9
,
3
1
–
3
3
,
3
5
–
3
7
,
4
1
,4
3
,
4
5
,
4
6
,
5
0
,
5
2
,5
4
,
6
0
,
6
2
,
6
6
,
6
7
]
“.
..
I
th
in
k
th
e
n
o
n
-m
ed
ic
al
p
re
sc
ri
b
in
g
le
ad
d
id
a
g
o
o
d
jo
b
in
se
tt
in
g
it
u
p
in
it
ia
ll
y
..
.w
e
ar
e
lu
ck
y
in
o
u
r
T
ru
st
b
ec
au
se
th
e
n
o
n
-m
ed
ic
al
p
re
sc
ri
b
in
g
le
ad
h
as
d
ri
v
en
it
fr
o
m
th
e
o
n
se
t,
h
e
w
as
o
n
e
o
f
th
e
fi
rs
t
su
p
p
le
m
en
ta
ry
p
re
sc
ri
b
er
s
an
d
h
e
h
as
d
ri
v
en
it
s
ri
g
h
t
fr
o
m
th
e
w
o
rd
g
o
re
al
ly
an
d
h
e
h
as
fo
u
g
h
t
lo
n
g
an
d
h
ar
d
to
g
et
it
re
co
g
n
iz
ed
an
d
th
at
’s
w
h
y
w
e
ar
e
in
th
e
p
o
si
ti
o
n
th
at
w
e
ar
e
in
n
o
w
.”
[2
7
]
“M
an
ag
em
en
t
ap
p
ea
re
d
th
re
at
en
ed
,
h
o
st
il
e
an
d
je
al
o
u
s
o
f
m
y
p
re
sc
ri
b
in
g
au
th
o
ri
ty
an
d
it
is
ex
tr
em
el
y
an
n
o
y
in
g
th
at
m
aj
o
r
d
ec
is
io
n
s
re
g
ar
d
in
g
n
u
rs
e
p
re
sc
ri
b
in
g
ar
e
m
ad
e
b
y
p
eo
p
le
in
m
an
ag
em
en
t
w
h
o
k
n
o
w
n
o
th
in
g
ab
o
u
t
it
”
[6
2
]
D
ev
el
o
p
m
en
t
an
d
im
p
le
m
en
ta
ti
o
n
o
f
N
M
P
,
en
ab
le
d
b
y
m
an
ag
er
ia
l
su
p
p
o
rt
,
in
cl
u
d
in
g
st
ro
n
g
st
ra
te
g
ic
v
is
io
n
.
Im
p
le
m
en
ta
ti
o
n
o
f
N
M
P
h
in
d
er
ed
th
ro
u
g
h
la
ck
o
f
u
n
d
er
st
an
d
in
g
o
r
o
rg
an
is
at
io
n
al
u
n
p
re
p
ar
ed
n
es
s
b
y
m
an
ag
er
s.
2
.2
.2
.
M
ed
ic
al
p
ro
fe
ss
io
n
al
s
[2
7
–
2
9
,
3
1
–
3
9
,
4
3
,
4
4
,
4
6
–
5
0
,
5
2
–
5
5
,
5
7
,
5
9
–
6
3
,
6
5
–
6
7
]
“T
ea
m
w
o
rk
in
g
g
iv
es
y
o
u
m
u
ch
m
o
re
in
fo
rm
at
io
n
ab
o
u
t
th
e
p
at
ie
n
t,
an
d
it
g
iv
es
y
o
u
m
u
ch
m
o
re
su
p
p
o
rt
if
y
o
u
n
ee
d
it
;
an
d
I
h
av
e
a
g
o
o
d
w
o
rk
in
g
re
la
ti
o
n
sh
ip
w
it
h
th
e
G
P
s
..
.
I
h
av
e
re
fe
rr
al
s
fr
o
m
th
e
p
ra
ct
ic
e
n
u
rs
e;
I
h
av
e
re
fe
rr
al
s
fr
o
m
th
e
d
o
ct
o
r
..
.S
o
I
th
in
k
th
e
cl
o
se
w
o
rk
in
g
re
la
ti
o
n
sh
ip
in
th
e
te
am
is
th
e
b
es
t
p
ar
t”
[4
3
]
“A
g
ai
n
m
y
an
x
ie
ty
is
la
rg
el
y
fo
r
th
e
n
u
rs
es
in
v
o
lv
ed
;
it
d
o
es
n
’t
se
em
at
th
e
m
o
m
en
t
cl
ea
r,
ex
ac
tl
y
w
h
at
th
ei
r
re
sp
o
n
si
b
il
it
y
is
an
d
if
th
er
e
is
a
m
es
s
u
p
,
w
h
o
ca
rr
ie
s
th
e
ca
n
.
I
am
n
o
t
cl
ea
r
if
a
n
u
rs
e
p
re
sc
ri
b
er
p
re
sc
ri
b
es
so
m
et
h
in
g
at
a
d
re
ad
fu
ll
y
w
ro
n
g
d
o
se
an
d
so
m
eb
o
d
y
is
h
ar
m
ed
as
a
re
su
lt
,
w
h
o
ca
rr
ie
s
th
e
ca
n
.
Is
th
at
m
y
M
D
U
su
b
sc
ri
p
ti
o
n
o
r
is
it
a
se
p
ar
at
e
th
in
g
?
I
th
in
k
th
o
se
ar
ea
s
ar
e
so
m
et
h
in
g
th
at
to
m
e
ar
e
n
o
t
en
ti
re
ly
cl
ea
r.
”[
3
9
]
D
o
ct
o
rs
u
n
d
er
st
an
d
in
g
an
d
ap
p
re
ci
at
in
g
b
en
ef
it
s
o
f
N
M
P
ro
le
,
in
cl
u
d
in
g
se
ek
in
g
ad
v
ic
e.
L
ac
k
o
f
cl
ar
it
y
o
v
er
ro
le
b
o
u
n
d
ar
ie
s
an
d
co
n
ce
rn
o
v
er
lo
ss
o
f
co
n
tr
o
l.
2
.2
.3
.
P
ee
rs
[2
7
,
2
8
,
3
1
,
3
2
,
3
4
–
3
6
,
3
8
,
4
1
,
4
3
,
4
4
,
4
6
–
4
9
,
5
2
,
5
3
,
5
5
,
5
7
,
5
8
,
6
2
,6
5
–
6
7
]
“L
o
n
g
te
rm
tr
u
st
in
g
re
la
ti
o
n
sh
ip
o
f
m
u
tu
al
re
sp
ec
t
b
et
w
ee
n
m
ed
ic
al
,
n
u
rs
in
g
an
d
o
th
er
h
ea
lt
h
ca
re
p
ro
fe
ss
io
n
al
s
an
d
m
y
se
lf
”
[4
3
]
“I
th
in
k
as
so
o
n
as
th
ey
re
al
iz
e
y
o
u
ca
n
p
re
sc
ri
b
e
th
ey
ex
p
ec
t
y
o
u
to
b
e
ab
le
to
d
o
ex
ac
tl
y
w
h
at
d
o
ct
o
rs
ca
n
d
o
.
T
h
ey
d
o
n
’t
u
n
d
er
st
an
d
y
o
u
r
li
m
it
at
io
n
s
an
d
y
o
u
ca
n
o
n
ly
w
o
rk
w
it
h
in
th
e
sc
o
p
e
o
f
y
o
u
r
k
n
o
w
le
d
g
e,
an
d
th
ey
ex
p
ec
t
y
o
u
to
si
g
n
re
p
ea
t
p
re
sc
ri
p
ti
o
n
s,
an
d
se
n
d
ev
er
y
b
o
d
y
th
ro
u
g
h
to
y
o
u
.
S
o
it
ca
n
b
e
q
u
it
e
d
if
fi
cu
lt
at
ti
m
es
ex
p
la
in
in
g
to
th
em
.”
[4
4
]
P
ee
r/
N
M
P
re
la
ti
o
n
sh
ip
p
ro
v
id
in
g
m
u
tu
al
su
p
p
o
rt
an
d
im
p
ro
v
in
g
te
am
w
o
rk
in
g
.
L
ac
k
o
f
u
n
d
er
st
an
d
in
g
o
f
N
M
P
an
d
/o
r
an
ta
g
o
n
is
m
h
in
d
er
in
g
N
M
P
.
(C
on
tin
ue
d)
Facilitators and barriers to non-medical prescribing
PLOS ONE | https://doi.org/10.1371/journal.pone.0196471 April 30, 2018 10 / 18
T
a
b
le
3
.
(C
o
n
ti
n
u
ed
)
T
h
em
e
S
u
b
,
a
n
d
su
b
su
b
,
th
em
es
Q
u
o
ta
ti
o
n
s
In
te
rp
re
ta
ti
o
n
/e
x
a
m
p
le
fa
ct
o
rs
3
.
O
rg
an
is
at
io
n
al
as
p
ec
ts
3
.1
.
A
d
m
in
is
tr
at
io
n
3
.1
.1
.
F
o
rm
u
la
ry
[2
7
,
2
9
,
3
1
–
3
3
,
3
6
,
3
7
,
4
3
,
4
7
,
4
8
,
5
1
,
5
2
,6
2
,
6
4
,
6
6
]
“Y
o
u
d
o
ta
k
e
ea
ch
p
at
ie
n
t
o
n
th
ei
r
o
w
n
m
er
it
b
u
t
w
it
h
in
th
at
fr
am
ew
o
rk
an
d
if
th
er
e
w
as
n
’t
th
at
fr
am
ew
o
rk
I
th
in
k
I
m
ig
h
t
b
e
fl
o
u
n
d
er
in
g
a
b
it
m
o
re
”
[3
1
]
“T
h
e
cl
in
ic
is
ac
tu
al
ly
li
m
it
in
g
th
e
ra
n
g
e
o
f
n
o
n
-H
IV
m
ed
ic
at
io
n
s
th
at
I
ca
n
p
re
sc
ri
b
e,
ev
en
if
m
an
y
o
f
th
es
e
ag
en
ts
p
ro
v
e
v
er
y
u
se
fu
l
in
tr
ea
tm
en
t
su
p
p
o
rt
ai
m
s.
”
[2
9
]
P
er
so
n
al
fo
rm
u
la
ry
u
se
d
to
d
ef
in
e
ar
ea
o
f
co
m
p
et
en
ce
,
an
d
su
p
p
o
rt
ed
b
y
n
at
io
n
al
g
u
id
el
in
es
.
F
o
rm
u
la
ry
re
st
ri
ct
io
n
s
d
er
iv
ed
fr
o
m
o
rg
an
is
at
io
n
al
p
o
li
cy
o
r
co
st
p
re
ss
u
re
s.
3
.1
.2
.
P
o
li
cy
[2
7
,
2
8
,
3
1
,3
6
,
4
3
,
4
7
,
6
2
,
6
6
]
“I
g
u
es
s
th
e
o
n
ly
th
in
g
th
at
I
w
o
u
ld
ch
an
g
e
is
b
y
h
av
in
g
st
an
d
ar
d
s
ac
ro
ss
th
e
co
u
n
tr
y
,
I
th
in
k
ea
ch
T
ru
st
is
al
lo
w
ed
to
ad
o
p
t
n
o
n
-m
ed
ic
al
p
re
sc
ri
b
in
g
w
it
h
in
th
ei
r
o
w
n
g
u
id
el
in
es
an
d
w
it
h
in
th
ei
r
re
m
it
an
d
I
th
in
k
it
’s
b
ee
n
g
o
o
d
in
so
m
e
ar
ea
s
b
u
t
it
h
as
h
in
d
er
ed
n
o
n
-m
ed
ic
al
p
re
sc
ri
b
in
g
in
so
m
e
o
th
er
s
an
d
it
h
as
n
o
t
al
lo
w
ed
th
em
to
d
ev
el
o
p
th
ei
r
p
ra
ct
ic
e,
as
th
ey
w
o
u
ld
d
o
.”
[2
7
]
“M
y
T
ru
st
h
as
n
o
g
u
id
el
in
es
an
d
th
er
e
is
n
o
g
u
id
an
ce
.
I
d
o
n
’t
k
n
o
w
an
y
o
n
e
in
o
u
r
ar
ea
w
h
o
is
p
re
sc
ri
b
in
g
”
[6
2
]
C
le
ar
p
o
li
cy
su
p
p
o
rt
in
g
N
M
P
,
an
d
ac
ti
n
g
as
sa
fe
g
u
ar
d
.
L
ac
k
o
f,
o
r
re
st
ri
ct
iv
e,
p
o
li
cy
h
in
d
er
in
g
N
M
P
d
ev
el
o
p
m
en
t
an
d
im
p
le
m
en
ta
ti
o
n
.
3
.1
.3
.
R
em
u
n
er
at
io
n
[2
7
,
3
7
,
4
3
,
4
6
,
5
0
,
5
4
,
6
0
,
6
2
]
“.
..
y
o
u
k
n
o
w
,
at
th
e
en
d
o
f
th
e
d
ay
,
I
am
d
o
in
g
it
n
o
t
fo
r
th
e
m
o
n
ey
an
d
n
o
t
fo
r
th
e
b
an
d
in
g
,
it
is
fo
r
m
y
p
ra
ct
ic
e
an
d
h
av
in
g
a
q
u
al
if
ic
at
io
n
th
at
al
lo
w
s
m
e
to
d
ev
el
o
p
m
y
p
ra
ct
ic
e
b
u
t
al
so
to
m
an
ag
e
m
y
ca
re
er
p
la
n
fo
r
th
e
fu
tu
re
,
if
y
o
u
li
k
e
..
.”
[2
7
]
“I
th
in
k
th
at
if
th
er
e
w
as
a
cl
ea
r
re
w
ar
d
in
ta
k
in
g
u
p
th
e
n
u
rs
e
p
re
sc
ri
b
in
g
m
an
te
l,
y
o
u
k
n
o
w
,
I
w
o
u
ld
b
e
p
re
sc
ri
b
in
g
n
o
w
”
[6
0
]
P
re
sc
ri
b
in
g
q
u
al
if
ic
at
io
n
fo
r
ro
le
ex
te
n
si
o
n
o
r
ca
re
er
p
ro
g
re
ss
io
n
,
n
o
t
fo
r
fi
n
an
ci
al
re
w
ar
d
.
L
ac
k
o
f
fi
n
an
ci
al
re
w
ar
d
se
en
as
d
is
in
ce
n
ti
v
e
to
tr
ai
n
in
g
an
d
u
n
ap
p
re
ci
at
iv
e
o
f
ro
le
.
3
.2
.
D
ev
el
o
p
m
en
t
3
.2
.1
.
P
o
st
co
u
rs
e
su
p
p
o
rt
[2
7
,
2
8
,
3
3
,
3
5
–
3
7
,
3
9
,
4
1
,
4
3
,
4
6
–
4
8
,
5
0
–
5
3
,
5
5
,
5
7
,
6
2
,
6
3
,
6
5
–
6
7
]
“I
su
p
p
o
rt
th
em
to
en
su
re
th
at
th
ey
h
av
e
ac
ce
ss
to
fu
rt
h
er
tr
ai
n
in
g
,
d
ev
el
o
p
m
en
t
an
d
[c
o
n
ti
n
u
o
u
s
p
ro
fe
ss
io
n
al
d
ev
el
o
p
m
en
t]
”
[2
8
]
“O
n
g
o
in
g
su
p
p
o
rt
h
as
g
o
n
e
v
er
y
h
it
an
d
m
is
s.
In
th
e
fi
rs
t
y
ea
r
th
er
e
w
er
e
a
fe
w
ev
en
in
g
se
ss
io
n
s
o
n
g
en
er
al
st
u
ff
,
n
o
t
sp
ec
if
ic
to
d
er
m
at
o
lo
g
y
.
N
o
w
w
it
h
al
l
th
e
re
o
rg
an
is
at
io
n
it
h
as
co
m
p
le
te
ly
h
it
th
e
b
in
an
d
y
o
u
d
o
n
’t
g
et
an
y
C
P
D
fr
o
m
th
e
em
p
lo
y
er
.”
[3
6
]
P
o
st
tr
ai
n
in
g
su
p
p
o
rt
n
ec
es
sa
ry
fo
r
co
n
ti
n
u
ed
d
ev
el
o
p
m
en
t
o
f
sk
il
ls
an
d
co
n
fi
d
en
ce
.
E
n
ab
le
d
b
y
p
ro
v
is
io
n
o
f
tr
ai
n
in
g
co
u
rs
es
,
an
d
m
an
ag
er
ia
l
su
p
p
o
rt
.
T
im
e
an
d
fu
n
d
in
g
p
ro
v
is
io
n
li
m
it
in
g
ac
ce
ss
to
co
u
rs
es
.
P
ee
r
an
d
p
ro
fe
ss
io
n
al
su
p
p
o
rt
ab
se
n
t.
3
.2
.2
.
T
ra
in
in
g
[2
7
,
2
8
,
3
0
,
3
3
,
3
5
,
3
9
,4
1
,
4
3
,
4
5
–
4
8
,
5
0
,
5
2
,
5
3
,
5
6
,
5
7
,
6
2
,
6
3
,6
7
]
“A
ll
ca
n
d
id
at
es
h
av
e
b
ee
n
re
q
u
ir
ed
to
[.
..
]
h
av
e
so
m
e
cl
ea
r
o
b
je
ct
iv
es
ar
o
u
n
d
th
e
n
ee
d
an
d
u
se
o
f
th
e
sk
il
ls
an
d
ab
il
it
y
to
p
re
sc
ri
b
e.
”
[4
5
]
“N
u
rs
es
th
at
h
av
e
d
o
n
e
co
u
rs
e
sa
y
[v
er
y
]
in
te
n
se
an
d
d
if
fi
cu
lt
.
I
h
av
e
tw
o
ch
il
d
re
n
an
d
am
si
n
g
le
p
ar
en
t–
so
li
m
it
ed
co
m
m
it
m
en
t
to
st
u
d
y
”
[5
0
]
P
ri
o
r
to
co
u
rs
e,
n
ee
d
fo
r
N
M
P
sh
o
u
ld
b
e
id
en
ti
fi
ed
,
an
d
ap
p
ro
p
ri
at
e
ca
n
d
id
at
es
se
le
ct
ed
.
R
o
le
o
f
cl
in
ic
al
m
en
to
r
cr
u
ci
al
fo
r
su
cc
es
sf
u
l
co
m
p
le
ti
o
n
.
T
im
e
an
d
co
u
rs
e
co
m
m
it
m
en
ts
o
ff
-p
u
tt
in
g
o
r
le
ad
in
g
to
ch
al
le
n
g
es
in
co
m
p
le
ti
n
g
co
u
rs
e.
3
.3
.
S
er
v
ic
e
d
el
iv
er
y
3
.3
.1
.
Im
p
ac
t
o
n
ti
m
e
[2
7
–
2
9
,
3
3
–
3
7
,
3
9
,
4
0
,
4
3
,
4
4
,
4
6
–
4
9
,
5
1
,
5
2
,
5
5
–
5
9
,
6
1
,
6
3
,
6
5
,
6
7
,
6
8
]
“I
th
in
k
it
’s
b
ec
au
se
o
f
ti
m
in
g
is
su
es
,
y
o
u
k
n
o
w
,
b
ec
au
se
n
o
rm
al
ly
if
it
’s
so
m
eo
n
e
w
h
o
h
as
ru
n
g
in
th
e
m
o
rn
in
g
,
th
en
th
ey
w
o
n
’t
g
et
a
G
P
v
is
it
ti
ll
th
e
af
te
rn
o
o
n
,
an
d
if
th
ey
’r
e
la
st
o
n
th
e
li
st
,
b
y
th
en
th
ey
’r
e
so
fa
r
d
o
w
n
th
e
li
n
e
th
ey
’r
e
in
h
o
sp
it
al
.
S
o
ti
m
in
g
is
su
es
ar
e
v
er
y
im
p
o
rt
an
t
in
m
an
ag
in
g
a
d
et
er
io
ra
ti
n
g
p
at
ie
n
t
..
.
y
o
u
g
et
it
o
n
b
o
ar
d
q
u
ic
k
er
;
I
m
ea
n
,
it
’s
a
1
2
-h
o
u
r
d
if
fe
re
n
ce
so
m
et
im
es
.”
[4
8
]
“O
h
,i
t
h
as
ch
an
g
ed
d
ra
m
at
ic
al
ly
.
W
o
rk
lo
ad
h
ad
tr
eb
le
d
.
W
e
se
e
m
o
st
o
f
th
e
m
in
o
r
ai
lm
en
ts
.
W
e
h
av
e
ta
k
en
a
lo
t
m
o
re
o
n
—
th
e
m
o
re
k
n
o
w
le
d
g
e
y
o
u
g
et
th
e
h
ig
h
er
th
e
w
o
rk
lo
ad
.
W
e
d
o
al
l
m
ed
ic
at
io
n
re
v
ie
w
s
an
d
al
l
h
y
p
er
te
n
si
o
n
re
v
ie
w
s”
[4
4
]
P
at
ie
n
ts
ab
le
to
re
ce
iv
e
ti
m
el
ie
r
an
d
st
re
am
li
n
ed
ca
re
w
it
h
N
M
P
.
A
b
il
it
y
to
p
re
sc
ri
b
e
sa
v
es
ti
m
e
fo
r
N
M
P
,
d
o
ct
o
r,
an
d
p
at
ie
n
t.
W
o
rk
lo
ad
p
re
ss
u
re
in
cr
ea
si
n
g
b
ec
au
se
o
f
p
re
sc
ri
b
in
g
.
3
.3
.2
.
In
fr
as
tr
u
ct
u
re
[2
7
,
3
1
–
3
4
,
3
6
–
3
8
,
4
3
,
4
6
–
4
9
,
5
1
,
5
2
,
5
4
,
5
7
,
6
2
–
6
4
,
6
7
]
“W
h
at
w
e
g
et
o
n
th
e
re
fe
rr
al
is
w
h
at
w
e
k
n
o
w
.
I
th
in
k
w
e’
v
e
h
ad
th
re
e
m
o
re
p
ra
ct
ic
es
n
o
w
g
o
o
n
to
th
e
sa
m
e
sy
st
em
w
e’
re
o
n
an
d
th
e
G
P
s
ar
e
fi
n
al
ly
co
m
in
g
ro
u
n
d
to
u
n
d
er
st
an
d
in
g
th
at
sh
ar
in
g
th
ei
r
n
o
te
s
is
a
b
en
ef
it
to
al
l
o
f
u
s.
S
o
it
is
im
p
ro
v
in
g
.
I’
v
e
n
o
w
g
o
t
tw
o
[G
P
p
ra
ct
ic
es
]
o
n
m
y
ca
se
lo
ad
w
h
er
e
I
ca
n
se
e
th
ei
r
n
o
te
s
as
w
el
l.
”
[3
7
]
‘‘
I
fe
el
th
at
p
h
ar
m
ac
y
in
d
ep
en
d
en
t
p
re
sc
ri
b
in
g
ca
n
o
n
ly
ta
k
e
p
la
ce
in
a
p
ri
m
ar
y
ca
re
se
tt
in
g
,
w
it
h
in
G
P
p
ra
ct
ic
es
.
T
h
is
is
b
ec
au
se
w
e
h
av
e
n
o
ac
ce
ss
to
p
at
ie
n
t
h
is
to
ry
an
d
n
o
te
s
o
th
er
w
is
e.
T
h
is
m
ak
es
p
re
sc
ri
b
in
g
fr
o
m
el
se
w
h
er
e
m
o
re
d
if
fi
cu
lt
an
d
p
o
ss
ib
ly
le
ss
ef
fe
ct
iv
e”
[5
4
]
P
re
sc
ri
b
in
g
su
p
p
o
rt
ed
b
y
g
o
o
d
ac
ce
ss
to
p
at
ie
n
t
re
co
rd
s,
p
ar
ti
cu
la
rl
y
el
ec
tr
o
n
ic
sy
st
em
s.
L
im
it
ed
o
r
n
o
ac
ce
ss
to
p
at
ie
n
t
re
co
rd
s
(i
n
cl
u
d
in
g
el
ec
tr
o
n
ic
)
p
re
v
en
ti
n
g
p
re
sc
ri
b
in
g
an
d
im
p
ed
in
g
g
o
o
d
co
m
m
u
n
ic
at
io
n
.
3
.3
.3
.
S
er
v
ic
e
[2
7
–
2
9
,
3
3
–
3
7
,
3
9
–
4
4
,
4
7
–
4
9
,
5
2
,
5
3
,
5
5
–
5
9
,
6
1
,
6
3
,
6
5
,
6
8
]
“I
ca
n
d
o
th
ei
r
p
re
sc
ri
p
ti
o
n
th
er
e
an
d
th
en
,
w
h
er
ea
s
so
m
et
im
es
th
ey
’d
h
av
e
to
co
m
e
b
ac
k
fo
r
it
.
F
o
r
th
e
y
o
u
n
g
er
p
eo
p
le
,
w
h
o
h
av
e
ta
k
en
ti
m
e
o
ff
w
o
rk
,
th
ey
d
o
n
’t
w
an
t
to
co
m
e
b
ac
k
ag
ai
n
,
an
d
so
m
et
im
es
th
ey
g
et
an
g
ry
o
r
fr
u
st
ra
te
d
if
it
p
u
ts
th
em
o
u
t,
so
y
es
,
it
’s
m
u
ch
,
m
u
ch
b
et
te
r
fo
r
th
em
th
at
it
’s
d
o
n
e
th
er
e
an
d
th
en
.”
[3
7
]
“A
t
th
e
m
o
m
en
t
w
e
o
n
ly
h
av
e
o
n
e
[n
u
rs
e
p
re
sc
ri
b
er
]
so
it
m
ak
es
it
im
p
o
ss
ib
le
if
X
is
o
ff
si
ck
fo
r
an
o
th
er
n
u
rs
e
to
d
o
h
er
cl
in
ic
w
it
h
o
u
t
a
lo
t
o
f
st
re
ss
fo
r
th
e
o
th
er
p
er
so
n
.
A
n
d
al
so
ti
m
e
co
n
su
m
in
g
fo
r
th
e
p
at
ie
n
ts
b
ec
au
se
th
at
n
u
rs
e
m
ig
h
t
h
av
e
al
l
th
e
k
n
o
w
le
d
g
e
an
d
sk
il
ls
b
u
t
th
ey
w
il
l
h
av
e
to
g
et
th
e
d
o
ct
o
r
to
co
m
e
in
b
ec
au
se
th
ey
h
av
e
n
o
t
d
o
n
e
th
e
p
re
sc
ri
b
in
g
co
u
rs
e.
”
[3
6
]
S
er
v
ic
e
to
p
at
ie
n
t
im
p
ro
v
ed
an
d
st
re
am
li
n
ed
,
w
it
h
im
p
ro
v
ed
p
at
ie
n
t
sa
ti
sf
ac
ti
o
n
an
d
ef
fi
ci
en
cy
.
S
er
v
ic
es
d
ep
en
d
en
t
o
n
N
M
P
s,
w
it
h
is
su
es
ar
is
in
g
w
h
en
N
M
P
s
ar
e
u
n
av
ai
la
b
le
.
3
.3
.4
.
U
se
in
p
ra
ct
ic
e
3
.3
.4
.1
.
P
at
ie
n
ts
[2
9
,
3
1
–
3
7
,
3
9
,
4
3
,
4
7
,
5
0
,
5
2
,
5
5
,
5
6
,
5
8
,
6
0
,6
4
–
6
8
]
“w
e
st
ar
te
d
o
n
e
p
at
ie
n
t
o
n
in
su
li
n
in
th
e
co
m
m
u
n
it
y
w
h
ic
h
is
fa
n
ta
st
ic
,
sa
v
ed
so
m
u
ch
h
as
sl
e
fo
r
a
d
em
en
te
d
m
an
n
o
t
to
h
av
e
to
g
o
in
to
h
o
sp
it
al
”
[3
1
]
“T
h
e
o
d
d
ti
m
e
y
o
u
g
et
p
eo
p
le
in
w
h
o
ar
e,
li
v
e
o
n
th
e
st
re
et
s,
y
o
u
k
n
o
w
,
I’
d
p
re
sc
ri
b
e
fo
r
th
em
,
an
d
y
o
u
ca
n
g
et
th
o
se
th
in
g
s
o
v
er
-t
h
e-
co
u
n
te
r
b
ec
au
se
th
ey
h
av
en
’t
g
o
t
th
e
m
o
n
ey
an
d
th
ey
g
et
fr
ee
p
re
sc
ri
p
ti
o
n
s”
[5
2
]
L
o
n
g
-t
er
m
co
n
d
it
io
n
s
su
ch
as
d
ia
b
et
es
.
C
o
m
p
le
x
p
at
ie
n
ts
su
ch
as
th
o
se
w
it
h
co
m
o
rb
id
it
ie
s.
M
in
o
r
ai
lm
en
ts
.
P
at
ie
n
ts
w
it
h
so
ci
al
n
ee
d
s
fo
r
ex
am
p
le
d
ru
g
u
se
rs
.
3
.3
.4
.1
.
S
et
ti
n
g
[3
1
,
3
6
,
3
7
,4
3
–
4
5
,
4
7
,
4
9
–
5
2
,
5
4
,
5
6
–
5
8
,
6
3
,
6
4
,
6
6
,
6
8
]
“A
m
aj
o
r
b
en
ef
it
o
f
se
ei
n
g
th
e
p
at
ie
n
t
in
th
ei
r
h
o
m
e,
in
a
se
tt
in
g
w
h
er
e
it
’s
to
th
ei
r
b
es
t
co
n
v
en
ie
n
ce
”
[6
3
]
“M
y
m
ai
n
d
ea
li
n
g
s
ar
e
tr
ea
ti
n
g
p
eo
p
le
w
it
h
ac
u
te
re
sp
ir
at
o
ry
p
ro
b
le
m
s.
T
h
ei
r
m
ed
ic
in
es
’(
ra
n
)
o
u
t,
o
r
th
ey
’r
e
b
ec
o
m
in
g
il
l
w
it
h
co
m
p
li
ca
ti
o
n
s.
T
h
at
’s
m
ai
n
ly
an
o
u
t
o
f
h
o
u
rs
se
tt
in
g
.
It
is
a
b
en
ef
it
fo
r
th
em
to
w
al
k
in
to
th
e
w
al
k
-i
n
ce
n
tr
e.
A
t
le
as
t
th
ey
’r
e
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remuneration. A formulary could be self-imposed [27, 31, 32, 48, 52], or organisation derived
[27, 29, 31, 32, 36, 62], and while they could be empowering [31, 36, 52, 66], they could be
restrictive [27, 29, 32, 36, 48, 52, 62]. Local policies could be supportive [27, 47, 66], restrictive
[27, 31, 43, 66], or missing [62]. Remuneration was considered to be non-commensurate with
skills [27, 43, 46, 50, 54, 60, 62]. Development covered both training, including selection for
course, as well as post course support. Course facilitators included appropriate selection of
candidates [35, 39, 41, 45, 47, 50], awareness of course commitments and requirements [48],
and support from medical mentors [43, 63], and managers [39, 41, 45]. Post course support
included the provision or facilitation of professional development courses [27, 36, 41, 47, 48,
67], mentoring [27, 41, 48, 50], and clinical supervision [27, 36, 66]. Absence of such support
hindered NMP development [27, 33, 35–37, 43, 46, 48, 52, 62, 63, 66, 67]. Infrastructure cov-
ered several issues, each with the potential to support or hinder, including access to: patient
records [27, 37, 43, 46, 49, 51, 52, 54, 63, 64], information technology [27, 31, 36, 38, 43, 48],
prescriptions [27, 31, 32, 37, 38, 43, 62, 67], and facilities [43, 49]. NMPs spent more time with
patients [35, 37, 39, 47, 49, 52, 55, 56, 63, 68], and were considered to provide a responsive, effi-
cient, and convenient service [27, 29, 33, 35–37, 40, 44, 47–49, 59, 65, 68]. Doctors’ time was
released by NMPs activity [29, 36, 43, 51, 63, 67], but time constraints and workload could hin-
der the NMP service [29, 34, 35, 44, 46, 49, 52, 63]. Some services were now reliant on NMPs
[36, 37] and had issues when cover was absent [36]. The settings and patient groups where
non-medical prescribing is utilised were diverse. Examples were given of utilising non-medical
prescribing to treat patients who may find accessing healthcare difficult such as frail and
housebound patients [37, 52, 63], the homeless [52], and drug users [43, 58]. Non-medical pre-
scribing was also utilised in more conventional healthcare settings such as specialist clinics (for
example, dermatology [36, 43], anti-coagulation [56], and cardiovascular [43]), minor illness
clinics [31, 36, 37, 44, 50], and out-of-hours services [36, 37, 52].
During analysis, it became apparent that many factors were not present in isolation
but were interdependent. Frequently, the interdependence was between a member of
staff, the NMP, an organisational aspect such as policy, and how this impacted on the
NMP’s confidence and ability to prescribe. Examples include a situation whereby a sup-
portive GP had given an NMP confidence to develop her competence area and expand
her personal prescribing formulary [27], and identification by NMP leads that an NMP
role was more likely to flourish when linked to a strategic vision and a well-defined area
of practice [41]. Other interdependencies were within organisational aspects, such as the
increased time required when the NMP was unable to easily access the patient’s notes
[37], or when the non-medical prescribing policy specifically supported access to con-
tinuing training [28].
Discussion
This is the first systematic review to investigate and synthesise the qualitative and mixed meth-
ods literature regarding barriers and facilitators to, and use of, independent non-medical pre-
scribing. Three overarching themes, each containing subthemes, were identified; the NMP,
human factors and organisational aspects. The themes and subthemes could all impact on suc-
cessful implementation of non-medical prescribing, and could be interdependent.
The NMP theme describes three aspects; one is intrinsic to the person (attitude), one
derives from their role, and the final one may be personally or externally derived. The later
subtheme ‘Area of competence’ was one of the four most highly mentioned aspects found dur-
ing analysis, highlighting its importance. This is supported by the ‘Competency framework for
all prescribers’ [8] and the NMC ‘Standards of proficiency for nurse and midwife prescribers’
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[9], which state that practitioners should only prescribe within their scope of practice (in con-
trast with the traditional medical model). There are implications if the NMP changes role, or
in planned service expansion, as further training and support in these new areas would be
required. Closely defined areas of competence could hamper full utilisation of non-medical
prescribing, particularly in patients with co-morbidities.
The second theme ‘human factors’ describes the complex interrelation between the NMP,
their managers, peers, the medical professions they work with, and their patients. This theme
included the most frequently mentioned subtheme ‘Medical professionals’, identified in 32
papers. It is notable that, in contrast with the review by Cooper et al, medical professionals
generally accepted the NMP role [16]. Reasons for acceptance may be because non-medical
prescribing has become established practice but also because NMPs have made deliberate
efforts to gain trust. There was an appreciation that the NMP role permitted medical profes-
sionals to concentrate on patients where their expertise was necessary. Changes in managerial
personnel could adversely impact on non-medical prescribing, particularly where systems and
processes were not embedded into practice. This review found that patients’ views of non-
medical prescribing were mixed, with many patients appreciating the time taken and holistic
approach of the NMP, whereas others expressed concerns. A lack of public understanding of
non-medical prescribing remains, even with patients treated by NMPs. Cooper et al noted that
very little research was identified investigating the views of patients about non-medical pre-
scribing [16]. This review identified one paper investigating public perception of non-medical
prescribing [51] and eight papers that included the views of patients [27, 28, 40, 49, 56, 59, 61,
68]; however, one of these only included quantitative ‘rating’ data from patients [40]. Research
into patients’ opinions of non-medical prescribing warrants further investigation.
The final theme covers the organisational aspects that support and enable an NMP to prac-
tice. It contains two of the four most frequently mentioned subthemes, ‘impact on time’ and
‘service’. In comparison to other subthemes, these two were frequently interdependent on
each other, with both highlighting the perceived improvement to patient care by providing a
streamlined, holistic, and convenient service. Funding pressures may make this aspect of the
service, appreciated by patients, difficult to sustain. This review identified that contingency
and succession planning should be considered during service development.
This review’s strength lies in its rigorous methodology and breadth of search strategy. This
compares with the previous investigations, which were limited in scope and rigour [14, 16].
The predetermined stringent protocol, registered with PROSPERO, and the use of two inde-
pendent reviewers are recognised strategies to reduce potential bias associated with paper
selection [20, 71]. Limitations included the inconsistent definitions used to describe NMPs,
which became apparent during the literature search. The terminology would have been appro-
priate when those studies were conducted, but the meaning changed as prescribing rights
evolved (see Table 1). Every effort was made to limit the included studies to those investigating
full independent non-medical prescribing. The nursing profession dominated the included
studies, with limited representation from pharmacist prescribers (mentioned in 11 papers [27,
33, 43, 47, 49, 52–55, 57, 61]) and none from other non-medical prescribing professions. This
reflects the relative numbers of the different professions [15, 72] and the numbers of qualified
prescribers [12]. However, the numbers of AHPS are likely to have increased recently follow-
ing legislation changes and that could be considered a limitation. Research into non-medical
prescribing by the other professions is needed to identify if they experience the same barriers
and facilitators.
The themes and subthemes identified in this review influence the implementation and
development of non-medical prescribing; each could act as a barrier or facilitator depending
on circumstances. Where there was a lack of understanding of the non-medical prescribing
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role, or lack of trust in the non-medical prescriber, then the factors were more inclined to be
barriers. For example, medical professionals were less likely to support non-medical prescrib-
ing where there was a lack of clarity about who took responsibility for the prescribing practice
[35, 39, 50]. Facilitation of NMP occurred when medical professionals trusted the NMP, for
example enabling access to patient records [37]. As a consequence of budgetary constraints,
factors may become barriers, such as the use of restrictive formularies as a cost saving measure
[37, 52, 64]. Additionally, this review has identified that these themes and subthemes do not
stand in isolation but are interdependent on each other. Each of these aspects should be con-
sidered when developing a non-medical prescribing service, and could be utilised as a model
for developing a non-medical prescribing strategy framework. This review will also inform
those currently managing or running a service, enabling service optimisation. Failure to
address all these aspects may mean that the full benefit of an NMP service will not be realised.
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